28
Emerging Dilemmas in Statin Use: Incident Diabetes, HIV Dyslipidemia, and Drug-Drug Interactions

Emerging Dilemmas in Statin Use: Incident Diabetes, HIV Dyslipidemia, and Drug-Drug Interactions

  • Upload
    marlie

  • View
    30

  • Download
    0

Embed Size (px)

DESCRIPTION

Emerging Dilemmas in Statin Use: Incident Diabetes, HIV Dyslipidemia, and Drug-Drug Interactions. Program Goals. Get With The Guidelines. The Framingham Study. Copenhagen Male Study: Risk of Ischemic Heart Disease (IHD) Associated With Higher TG and Lower HDL-C. Intensive Statin Therapy. - PowerPoint PPT Presentation

Citation preview

Page 1: Emerging Dilemmas in Statin Use:  Incident Diabetes, HIV Dyslipidemia, and Drug-Drug Interactions

Emerging Dilemmas in Statin Use: Incident Diabetes, HIV Dyslipidemia,

and Drug-Drug Interactions

Page 2: Emerging Dilemmas in Statin Use:  Incident Diabetes, HIV Dyslipidemia, and Drug-Drug Interactions
Page 3: Emerging Dilemmas in Statin Use:  Incident Diabetes, HIV Dyslipidemia, and Drug-Drug Interactions

Program Goals

Page 4: Emerging Dilemmas in Statin Use:  Incident Diabetes, HIV Dyslipidemia, and Drug-Drug Interactions

Get With The Guidelines

Page 5: Emerging Dilemmas in Statin Use:  Incident Diabetes, HIV Dyslipidemia, and Drug-Drug Interactions

The Framingham Study

Page 6: Emerging Dilemmas in Statin Use:  Incident Diabetes, HIV Dyslipidemia, and Drug-Drug Interactions

Copenhagen Male Study: Risk of Ischemic Heart Disease (IHD) Associated With Higher TG and

Lower HDL-C

Page 7: Emerging Dilemmas in Statin Use:  Incident Diabetes, HIV Dyslipidemia, and Drug-Drug Interactions

Intensive Statin Therapy

Page 8: Emerging Dilemmas in Statin Use:  Incident Diabetes, HIV Dyslipidemia, and Drug-Drug Interactions

Guideline Recommendations

Page 9: Emerging Dilemmas in Statin Use:  Incident Diabetes, HIV Dyslipidemia, and Drug-Drug Interactions

Approximate Dose Equivalency of Statin LDL-C Efficacy

Page 10: Emerging Dilemmas in Statin Use:  Incident Diabetes, HIV Dyslipidemia, and Drug-Drug Interactions

The Statin Armamentarium: Individual Metabolism

Characteristics

Page 11: Emerging Dilemmas in Statin Use:  Incident Diabetes, HIV Dyslipidemia, and Drug-Drug Interactions

CYP Inhibitors: Drug-Drug Interactions

Page 12: Emerging Dilemmas in Statin Use:  Incident Diabetes, HIV Dyslipidemia, and Drug-Drug Interactions

Statin Use in Diabetes: Cardiovascular Events

Page 13: Emerging Dilemmas in Statin Use:  Incident Diabetes, HIV Dyslipidemia, and Drug-Drug Interactions

Effect of Statins on New-onset T2D

Page 14: Emerging Dilemmas in Statin Use:  Incident Diabetes, HIV Dyslipidemia, and Drug-Drug Interactions

JUPITER: Rosuvastatin and New-Onset T2D

Page 15: Emerging Dilemmas in Statin Use:  Incident Diabetes, HIV Dyslipidemia, and Drug-Drug Interactions

Glucose Control: Differential Influence of Statins

Page 16: Emerging Dilemmas in Statin Use:  Incident Diabetes, HIV Dyslipidemia, and Drug-Drug Interactions

J-PREDICT: Pitavastatin May Reduce New-Onset T2D

Page 17: Emerging Dilemmas in Statin Use:  Incident Diabetes, HIV Dyslipidemia, and Drug-Drug Interactions

Dyslipidemia in HIV

Page 18: Emerging Dilemmas in Statin Use:  Incident Diabetes, HIV Dyslipidemia, and Drug-Drug Interactions

Statins and HAART Drug-Drug Interactions

Page 19: Emerging Dilemmas in Statin Use:  Incident Diabetes, HIV Dyslipidemia, and Drug-Drug Interactions

Lipid-Lowering Therapy in HIV

Page 20: Emerging Dilemmas in Statin Use:  Incident Diabetes, HIV Dyslipidemia, and Drug-Drug Interactions

Glucose Control in HIV

Page 21: Emerging Dilemmas in Statin Use:  Incident Diabetes, HIV Dyslipidemia, and Drug-Drug Interactions

INTREPID: Effects of Pitavastatin vs Pravastatin in HIV Dyslipidemia

Page 22: Emerging Dilemmas in Statin Use:  Incident Diabetes, HIV Dyslipidemia, and Drug-Drug Interactions

Summary

Page 23: Emerging Dilemmas in Statin Use:  Incident Diabetes, HIV Dyslipidemia, and Drug-Drug Interactions

Abbreviations

Page 24: Emerging Dilemmas in Statin Use:  Incident Diabetes, HIV Dyslipidemia, and Drug-Drug Interactions

Abbreviations (cont)

Page 25: Emerging Dilemmas in Statin Use:  Incident Diabetes, HIV Dyslipidemia, and Drug-Drug Interactions

References

Page 26: Emerging Dilemmas in Statin Use:  Incident Diabetes, HIV Dyslipidemia, and Drug-Drug Interactions

References (cont)

Page 27: Emerging Dilemmas in Statin Use:  Incident Diabetes, HIV Dyslipidemia, and Drug-Drug Interactions

References (cont)

Page 28: Emerging Dilemmas in Statin Use:  Incident Diabetes, HIV Dyslipidemia, and Drug-Drug Interactions

References (cont)